A Hypertension Drug Requiring Less-Frequent Dosing Than Novartis's Diovan/Tareg Would Earn Similar Patient Share in Europe and U.S.

Friday, January 8, 2010 Hypertension News
Email Print This Page Comment bookmark
Font : A-A+

The Fixed-Dose Combination Telmisartan/Amlodipine Will Become the New Decision Resources Clinical Gold Standard for Hypertension in 2013

For more information, contact:

Decision Resources

Decision Resources, Inc.

Gisselle Morales

Elizabeth Marshall

781-296-2691

781-296-2563

gmorales@dresources.com

emarshall@dresources.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store